The increased buyback target suggests management views shares as undervalued and expects strong cash generation. Monitor future earnings for cash flow updates and actual execution pace of repurchases. The buyback may provide downside support.
Price Chart
Executive Summary
Zimmer Biomet announced an increased share repurchase expectation for FY2026, now targeting up to $1.0 billion in buybacks under its existing $1.5 billion authorization. This represents a $250 million increase from prior capital allocation assumptions, signaling management's confidence in cash flow and commitment to returning capital.
Key Facts
- Company intends to repurchase up to $1.0 billion of shares in FY2026
- Increase of $250 million from prior capital allocation assumption
- Repurchases under existing $1.5 billion authorization approved in February 2026
- No changes to the size, duration or terms of the authorization
Financial Impact
Up to $1.0 billion in share repurchases
Risk Factors
- Actual repurchases depend on market conditions, stock price, and capital availability
- No commitment to execute full $1.0 billion; timing and amount variable
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-218098 |
| Document: zbh-ex99_1.htm | 0001193125-26-218098 |
| Document: 0001193125-26-218098-index-headers.html | 0001193125-26-218098 |
| Document: 0001193125-26-218098-index.html | 0001193125-26-218098 |
| Document: 0001193125-26-218098.txt | 0001193125-26-218098 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $98.41 $93.98 | ▼ −4.50% | ▼ −6.63% | $87.94 (−10.64%) |
Sep 2, 2026 4w ago | Court Ruling | $99.50 $92.44 | ▼ −7.10% | ▼ −6.14% | $87.94 (−11.62%) |
Aug 17, 2026 6w ago | Court Ruling | $98.20 $100.98 | ▲ +2.83% | ▲ +4.02% | $87.94 (−10.45%) |
Aug 5, 2026 8w ago | 8-K | $98.16 $97.89 | ▼ −0.28% | ▼ −0.63% | $87.94 (−10.41%) |
May 12, 2026 20w ago | 8-K | $83.34 $85.14 | ▲ +2.16% | ▲ +2.09% | $87.94 (+5.52%) |
May 1, 2026 22w ago | Court Ruling | $82.86 $83.37 | ▲ +0.62% | ▼ −1.73% | $87.94 (+6.14%) |
Apr 28, 2026 22w ago | 8-K | $82.45 $82.63 | ▲ +0.22% | ▼ −1.47% | $87.94 (+6.66%) |
Apr 28, 2026 22w ago | 8-K | $82.45 $82.63 | ▲ +0.22% | ▼ −1.47% | $87.94 (+6.66%) |
Apr 1, 2026 26w ago | DEFA14A | $91.00 $93.03 | ▲ +2.24% | ▼ −1.53% | $87.94 (−3.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access